Shares of Ironwood Pharmaceuticals (NASDAQ:IRWD) remained unaffected after the company reported Q4 results.
Quarterly Results
Earnings per share increased 20.00% over the past year to $0.36, which beat the estimate of $0.29.
Revenue of $116,680,000 decreased by 7.62% from the same period last year, which beat the estimate of $111,950,000.
Guidance
Ironwood Pharmaceuticals sees FY21 sales of $370 million-$385 million.
Details Of The Call
Date: Feb 17, 2021
Time: 08:30 AM
Technicals
Company's 52-week high was at $13.07
52-week low: $7.99
Price action over last quarter: down 6.09%
Company Description
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
Posted In:
